How much funding has Stablix raised?

Stablix has raised $63.0M in total funding, most recently a Series A round.

Who are Stablix's investors?

Stablix's investors include Jerel Davis, NEA, Access Industries.

Where is Stablix headquartered?

Stablix is headquartered in New York, New York, United States.

What industry is Stablix in?

Stablix operates in Biotech, Healthcare.

Stablix

Protein Stabilization Therapeutics

New York, United States · Founded 2021 · $63.0M raised

Biotech

Healthcare

Headquarters: New York, New York
Employees: 11–50
Founded: 2021
Business Model: B2B

Website: stablix.com
Total Funding: $63.0M
Last Round: $63.0M Series AJun 2021
Rounds: 1

About

Stablix is pioneering an entirely new field of targeted protein stabilization (TPS) to bring transformative medicines to patients with unmet medical need.

Summary

Stablix is a Biotech company based in New York, United States, founded in 2021. It has raised $63.0M in total across 1 round, most recently a $63.0M Series A round in Jun 2021. Investors include Jerel Davis, NEA and Access Industries.

LinkedIn X (Twitter)